Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexually transmitted infections news

Show

From To
Tenth of British men 'pay for sex'

More than one in 10 men have paid for sex, according to a major study of British sexual habits.

Published
18 November 2014
From
BBC Health
Gay men in UK recommended to receive HPV vaccination

HPV vaccination programmes should be extended to gay and other men who have sex with men (MSM), an interim statement issued by the UK’s expert vaccine committee

Published
14 November 2014
By
Michael Carter
Gay men 'should get anti-cancer jab'

The HPV vaccine should be given to men who have sex with men, according to the government's experts. It is is already given to schoolgirls in the UK, but there have been calls for the vaccination programme to be extended. The Joint Committee on Vaccination and Immunisation now recommends offering the jab at sexual health clinics to men who have sex with men, aged between 16 and 40.

Published
12 November 2014
From
BBC News
Missed HPV vaccination opportunities: a consequence of avoiding awkward conversations

In the US, routine administration of quadrivalent HPV vaccine is recommended for girls and boys at 11-12 yrs, with catch-up vaccination recommended up to 26 yrs for girls, and 21 yrs for boys.  The difficulty has been in the implementation of the recommendation: overall rates of initiating and completion among US teenage girls currently stand at 57% and 35% respectively.

Published
11 November 2014
From
BMJ
Dissolving Tampons Deliver HIV Drugs (and Maybe Contraception, Too)

University of Washington researchers have created a discreet, quick-dissolving tampon out of silk-line fibers to protect women from HIV. The researchers would ideally like to develop a tampon to protect against HIV, herpes, and pregnancy — an all-in-one shield against the risks of sex. This could prove especially useful in developing countries, where women may not have easy access to other kinds of birth control.

Published
04 November 2014
From
Healthline News
New syphilis more than doubles chance of HIV in MSM PrEP trial

Getting syphilis more than doubled chances of HIV acquisition in the iPrEx preexposure prophylaxis (PrEP) trial in men who have sex with men (MSM) and transgender women. But having syphilis did not diminish the protective benefit of daily tenofovir/emtricitabine (TDF/FTC) PrEP against HIV.

Published
04 November 2014
From
International AIDS Society
Tenofovir gel use associated with lower HSV-2 risk in women

The risk of acquiring herpes simplex virus type 2 (HSV-2) was reduced by 46% (aIRR:0.54, 95%CI:0.30-0.97, p = 0.038) among women who regularly used the vaginal gel containing

Published
30 October 2014
By
Lesley Odendal
Are antimicrobial condoms the new frontier against STIs? Not quite…

Australian biotech company Starpharma has announced the imminent launch of a condom coated with an antimicrobial chemical known as VivaGel. While it might be marketed as a great leap forward for preventing sexually transmitted infections (STIs), it’s unlikely to offer any more protection than your average condom.

Published
14 October 2014
From
The Conversation
Tobacco use associated with increased risk of oral HPV-16 infection

Study participants who reported tobacco use or had higher levels of biomarkers of tobacco exposure had a higher prevalence of the sexually transmitted infection, oral human papillomavirus type 16, according to a study in the Oct. 8 JAMA, a theme issue on infectious disease. HPV-16 is the most common cancer-causing variety of HPV.

Published
08 October 2014
From
Eurekalert
Population-based evidence for the preventative efficacy of quadrivalent HPV in Australia

A recently published study claims to provide the first whole population analysis of the impact on genital warts of a national HPV vaccination programme – and this may be the best predictor of the longer-term, and more important, cancer prevention benefits to be seen in future years. The findings show a decline of 89.9% in admissions involving warts from 2006/7 to 2010/11 for girls aged 12-17 yrs, a decline of 72.7% for women aged 18-26, and a decline of 38% for men aged 18-14 (the indirect effect of female vaccination).

Published
01 October 2014
From
BMJ Group blogs
← First12345...58Next →

Filter by country